NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

Do you think his articles, in conjunction with the hammering NWBO’s share price has suffered, has had any impact on their ability to move forward with Direct trials?

Probably. But this is an OTC stock. There are no institutional investors. AF has probably kept a lot of money out of this stock, but not enough that we would be in a much different place than we are now anyway. We are where we are because of the way the company has (mis)managed this trial, and the truth is that 90 percent of what AF has written is completely accurate.